Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 7, 2010, Pages 1424-1427

  Darby, Crystal M ^a,b   Nathan, Carl F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Medical Center   (United States)

Author keywords

Hydroxyquinolines; M. tuberculosis; TB

Indexed keywords

8 QUINOLINOL; SODIUM NITRITE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BROTH DILUTION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; GENE REPLICATION; IMMUNODIFFUSION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH; ANIMAL; BACTERIAL COUNT; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MUTATION; TOXICITY; VERO CELL LINE;

ANIMALS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXYQUINOLINE; VERO CELLS;

EID: 77954185230     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq145     Document Type: Article

References (12)

1. Murugasu-Oei B, Dick T. In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG. Int J Antimicrob Agents 2001; 18: 579-82.
2. Hongmanee P, Rukseree K, Buabut B et al. In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 1105-6.
3. Tison F. The remarkable effect of a combination of iodochloroxyquinoline with a subactive dose of streptomycin on experimental tuberculosis in guinea pigs. Ann Inst Pasteur 1952; 83:275-6.
4. Ritchie CW, Bush AI, Mackinnon A et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 2003; 60: 1685-91.
5. Ananthan S, Faaleolea ER, Goldman RC et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis 2009; 89: 334-53.
6. Duman N, Cevikbas A, Johansson C. The effects of rifampicin and fluoroquinolones on tubercle bacilli within human macrophages. Int J Antimicrob Agents 2004; 23:84-7.
7. Via LE, Lin PL, Ray SM et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008; 76: 2333-40. JAC
8. Aly S, Wagner K, Keller C et al. Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol 2006; 210: 298-305.
9. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003; 302:654-9.
10. Nathan C. Role of iNOS in human host defense. Science 2006; 312: 1874-5.
11. de Carvalho LP, Lin G, Jiang X et al. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance. J Med Chem 2009; 52: 5789-92.
12. Silver LL. Multi-targeting by monotherapeutic antibacterials. Nat Rev Drug Discov 2007; 6: 41-55.